Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
67.00    0.00 (0.00%)
Bid:
67.00
Ask:
67.40
Spread: 0.40 (0.597%)
Market Cap: £90.43m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Non-Executive Director Appointment

17 Jun 2009 07:00

RNS Number : 0108U
Trifast PLC
17 June 2009
 



Issued by Citigate Dewe Rogerson Ltd, Birmingham

Date: Wednesday, 17 June 2009

Trifast plc

Non-Executive Director Appointment

Trifast plc ('Trifast' or ''the Company') announces the appointment to the Board with effect from 1 July 2009 of Jonathan Shearman as a Non-Executive Director and Chairman of the Company's Remuneration Committee. 

Jonathan, (aged 38) has extensive City experience having worked for over 15 years within the UK Small-Cap arena. He holds a BSc. in Economics and Economic History and an Investment Management Certificate. Jonathan started his career in the Midlands in 1993 and spent 10 years with HSBC James Capel/Williams De Broe where he became Head of Equity Sales and played a major role in the team achieving 'Top3 Extel rated' status. After a brief spell with KBC Peel Hunt, he joined the successful and highly regarded Small Cap investment team at Gartmore Investment Management, a position he held until 2008. Over the same time, Jonathan became heavily involved with the Christian CentreNottingham where he now chairs the strategic planning committee and also is responsible for the line management of several key members of staff.  In addition, Jonathan is now employed (on a part-time basis) to advise, primarily within the securities division, on strategy to the leading European investment banking group, Altium, a position he has held since March of this year.

Commenting on Jonathan's appointment, Malcolm Diamond MBE, Executive Chairman said:

"We are delighted Jonathan has joined the TR team; he has extensive experience working with both UK and international small to mid-market corporates. He has clearly demonstrated through his successful City career that he has the ability to be analytical and systematic in his thought processI believe that these skills, when added to those that already exist within the TR leadership team, will benefit the senior management and their people as we all work together to implement our revised strategy, which will provide the solid foundation to reposition the business for the future."

Jonathan joins Neil Chapman BA, FCA who was appointed to the New Trifast Board in March 2009 as Senior Independent Non-Executive Director and Chairman of the Company's Audit Committee.

There are no other matters which require to be disclosed pursuant to paragraph 9.6.13 of the Listing Rules.

Enquiries:

Trifast plc

Citigate Dewe Rogerson

Malcolm Diamond MBE, Executive Chairman

Fiona Tooley, Director

Jim Barker, Chief Executive

Keith Gabriel, Senior Account Manager

Tel: +44 (0)1825 747366

Tel: +44(0) 362 4035

Mobile: +44 (0) 7979 518493 (MMD)

Mobile: +44 (0)7785 703523 (FMT)

Arden Partners plc

Richard Day

Adrian Trimmings 

Tel:+44 (0) 20 7398 1600

Editors Note:

Ticker: TRI.L

Group website: www.trifast.com

Trifast's trading business; TR Fastenings is a leading international manufacturer and distributor of industrial fastenings to the assembly industries, with operations in Europe, the Americas and Asia. For more information, please visit www.trfastenings.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKQLFFKQBBBBZ
Date   Source Headline
11th Jun 20267:00 amRNSChange of Adviser
3rd Jun 20267:46 amRNSDirector Declaration
5th May 20261:03 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSTrading Statement
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20261:44 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSHolding(s) in Company
27th Mar 20262:53 pmRNSHolding(s) in Company
27th Mar 20262:43 pmRNSDirector/PDMR Shareholding
17th Feb 20261:15 pmRNSDirector/PDMR Shareholding
16th Feb 20263:02 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTrading Statement
19th Jan 20268:34 amRNSDirector Declaration
9th Jan 202611:02 amRNSDirector/PDMR Shareholding
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSHalf-year Financial Report
23rd Oct 20255:10 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSTrading Statement
15th Oct 20253:06 pmRNSDirector/PDMR Shareholding
7th Oct 20259:01 amRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNSBoard Fellow Appointment
11th Sep 20251:31 pmRNSResult of AGM
11th Sep 20257:00 amRNSTrading Statement
5th Sep 20253:00 pmRNSDirector/PDMR Shareholding
18th Aug 20251:21 pmRNSDirector/PDMR Shareholding
28th Jul 20253:19 pmRNSDirector/PDMR Shareholding
22nd Jul 20258:08 amRNSNotice of AGM
14th Jul 20251:44 pmRNSDirector/PDMR Shareholding - Replacement
14th Jul 20251:17 pmRNSDirector/PDMR Shareholding
10th Jul 20257:00 amRNSFinal Results
27th Jun 20252:50 pmRNSNotice of Results
4th Jun 20257:00 amRNSTotal Voting Rights
19th May 20255:02 pmRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Update & Notice of FY25 Annual Results
16th Apr 20253:02 pmRNSShare purchases under Dividend Re-Investment Plan
11th Apr 20257:00 amRNSDirector/PDMRs share purchases
2nd Apr 20251:25 pmRNSBlock listing Interim Review
27th Mar 20252:15 pmRNSDirector/PDMR Shareholding
24th Mar 202512:12 pmRNSDirector/PDMR Shareholding - Purchase of Shares
13th Feb 20257:00 amRNSTrading update
5th Feb 202511:19 amRNSDirector/PDMR Shareholding
4th Feb 20253:54 pmRNSDirector/PDMR Shareholding
28th Jan 20252:07 pmRNSDirector/PDMR Shareholding
27th Jan 20255:15 pmRNSDirector/PDMR Shareholding
23rd Jan 20255:27 pmRNSHolding(s) in Company
11th Dec 20241:58 pmRNSHolding(s) in Company
11th Dec 20241:55 pmRNSDirector/PDMR Shareholding
10th Dec 20243:23 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.